Xtandi 40 MG capsule 120S

Ended Awarded

Contract number
SPE2DR26FKBD2
Awardee
Awarding agency
Obligated
$4,422

Award facts

Contract value 100% obligated
$4,422.16 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $4,422.16 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on June 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Xtandi 40 mg capsules (120 count). Ultimate completion date is June 25, 2026. Place of performance is Park Ridge, Illinois. PPV-G GEN V is DLA's $30.3 billion single-award indefinite delivery contract framework authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to Department of Defense military healthcare facilities worldwide.

Quick answers

Who was awarded contract SPE2DR26FKBD2?

SPE2DR26FKBD2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 24, 2026.

How much is contract SPE2DR26FKBD2 worth?

The government has obligated $4,422 on SPE2DR26FKBD2.

Is contract SPE2DR26FKBD2 an order under another contract?

Yes. SPE2DR26FKBD2 is a delivery order under SPE2DR25D9365, an indefinite delivery contract.

Was contract SPE2DR26FKBD2 competed?

The extent of competition for SPE2DR26FKBD2 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award